University of Oklahoma
531
90
125
277
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.4%
87 terminated/withdrawn out of 531 trials
76.1%
-10.4% vs industry average
8%
42 trials in Phase 3/4
36%
101 of 277 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (531)
Efficacy of the Buzzy System on Pain and Fear Reduction in Elbow Fracture Pin Removal
Role: lead
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
Role: lead
Outcomes in Simulated Endoscopy Training
Role: lead
The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study
Role: lead
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
Role: lead
Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer
Role: lead
Smoking Cessation Program for Lao People With HIV
Role: lead
Promoting Active Living Among People With Metastatic Breast Cancer
Role: lead
Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer
Role: lead
Advanced or Recurrent Solid Tumors Treated With SHetA2
Role: lead
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Role: lead
Autoimmune Basis for Postural Tachycardia Syndrome
Role: lead
Project Q: Cue-based Treatment Intervention to Promote Cessation Among People Who Smoke Lightly or Non-daily
Role: collaborator
Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment
Role: lead
Disulfiram in Rheumatoid Arthritis
Role: lead
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
Role: lead
Mobile Contingency Management for Smoking Cessation
Role: lead
RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkS
Role: collaborator
Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy
Role: lead
Pilot Window of Opportunity Trial (POET)
Role: lead